BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6195126)

  • 1. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
    Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
    Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
    Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status in lung cancer: effects of BCG immunotherapy.
    Gross NJ; Eddie-Quartey AC
    Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of lung cancer.
    Zubrod CG; Selawry O
    Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapleural BCG in operable lung cancer.
    Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
    Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Livingston's chemotherapy combined with immunotherapy in treatment of small cell lung carcinoma.
    Szklarz E; Jaszczołt M; Woźnicki Z; Głuszczyk-Ferenc B
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):641-9. PubMed ID: 2484836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New method of immunotherapy for lung cancer.
    Holmes EC; Ramming KP; Mink J; Coulson WF; Morton DL
    Lancet; 1977 Sep; 2(8038):586-7. PubMed ID: 71401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
    Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
    Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
    Yamamura Y; Sakatani M; Ogura T; Azuma I
    Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.